Risk of renal failure with the non‐vitamin K antagonist oral anticoagulants: systematic review and meta‐analysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1557|24|7|757-764

ISSN： 1053-8569

Source： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol.24, Iss.7, 2015-07, pp. : 757-764

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systematic review with meta‐analysis: the risk of major gastrointestinal bleeding with non‐vitamin K antagonist oral anticoagulants

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 11-12, 2015-12 ,pp. : 1239-1249

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non‐vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta‐analysis of randomized trials

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 11, 2015-11 ,pp. : 1192-1200

John Wiley & Sons Inc

Access to resources Recommend Favorite

Practical Considerations for the Nonvitamin K Antagonist Oral Anticoagulants

By  

Cardiology, Vol. 136, Iss. 2, 2016-09 ,pp. : 115-124

Karger

Access to resources Recommend Favorite

Use of non‐vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 11, 2015-11 ,pp. : 1341-1348

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vitamin K antagonists' use and fracture risk: results from a systematic review and meta‐analysis

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 9, 2015-09 ,pp. : 1665-1675

John Wiley & Sons Inc

Access to resources Recommend Favorite